Repository logo
 
Publication

Type 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteins

dc.contributor.authorReis, Ana
dc.contributor.authorRocha, Sara
dc.contributor.authorDias, Irundika HK.
dc.contributor.authorCosta, Raquel
dc.contributor.authorSoares, Raquel
dc.contributor.authorSánchez-Quesada, José Luis
dc.contributor.authorPerez, Antonio
dc.contributor.authorFreitas, Victor de
dc.date.accessioned2023-01-04T18:28:12Z
dc.date.available2023-01-04T18:28:12Z
dc.date.issued2023-02
dc.description.abstractThe incidence of diabetes on the worldwide population has tripled in the past 5 decades. While drug-based therapies are valuable strategies to treat and ease the socio-economic burden of diabetes, nutritional strategies offer valuable alternatives to prevent and manage diabetes onset and contribute to the sustainability of health budgets. Whilst, intervention studies have shown that (poly)phenol-rich diets improve fasting glucose levels and other blood parameters, very little is known about the distribution of ingested polyphenols in circulation and the impact of diabetes on its cargo. In this study we investigate the impact of type 2 diabetes on the cargo of plasma (poly)phenols. Our results show that phenolic compounds are heterogeneously distributed in circulation though mainly transported by lipoprotein populations. We also found that diabetes has a marked effect on the phenolic content transported by VLDL resulting in the decrease in the content of flavonoids and consequently a decrease in the antioxidant capacity. In addition to the reduced bioavailability of (poly)phenol metabolites and increase of oxidative status in LDL and HDL populations in diabetes, cell-based assays show that sub-micromolar amounts of microbial (poly)phenol metabolites are able to counteract the pro-inflammatory status in glucose-challenged endothelial cells. Our findings highlight the relevance of triglyceride-rich lipoproteins in the transport and delivery of bioactive plant-based compounds to the endothelium in T2DM supporting the adoption of nutritional guidelines as an alternative strategy to drug-based therapeutic approaches.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1016/j.redox.2022.102572pt_PT
dc.identifier.eid85143865332
dc.identifier.issn2213-2317
dc.identifier.pmcPMC9762197
dc.identifier.pmid36516720
dc.identifier.urihttp://hdl.handle.net/10400.14/39737
dc.identifier.wos000907983800001
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectDiabetespt_PT
dc.subjectEndothelial cellpt_PT
dc.subjectFlavonoidspt_PT
dc.subjectInflammatory cytokinespt_PT
dc.subjectMicrobial metabolitespt_PT
dc.subjectOxidised phosphatidylcholines (oxPC)pt_PT
dc.titleType 2 Diabetes mellitus alters the cargo of (poly)phenol metabolome and the oxidative status in circulating lipoproteinspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleRedox Biologypt_PT
oaire.citation.volume59pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
1_s2.0_S2213231722003445_main.pdf
Size:
822.76 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.44 KB
Format:
Item-specific license agreed upon to submission
Description: